0001691275-16-000001.txt : 20161206 0001691275-16-000001.hdr.sgml : 20161206 20161205183615 ACCESSION NUMBER: 0001691275-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161206 DATE AS OF CHANGE: 20161205 EFFECTIVENESS DATE: 20161206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Expansion Therapeutics, Inc. CENTRAL INDEX KEY: 0001691275 IRS NUMBER: 814414709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-275680 FILM NUMBER: 162034864 BUSINESS ADDRESS: STREET 1: 491 PINE NEEDLES DRIVE CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: (650) 430-5836 MAIL ADDRESS: STREET 1: 491 PINE NEEDLES DRIVE CITY: DEL MAR STATE: CA ZIP: 92014 D 1 primary_doc.xml X0707 D LIVE 0001691275 Expansion Therapeutics, Inc. 491 PINE NEEDLES DRIVE DEL MAR CA CALIFORNIA 92014 (650) 430-5836 DELAWARE None None Corporation true 2016 Kevin Forrest c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Executive Officer Director Matthew Disney c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Director Scott Rocklage c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Executive Officer Director Paul Stone c/o Expansion Therapeutics, Inc. 491 Pine Needles Drive Del Mar CA CALIFORNIA 92014 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2016-11-28 false true true Consists of Convertible Promissory Notes convertible into shares of preferred stock of the Issuer. false 0 4000000 250000 3750000 false 2 0 0 0 false Expansion Therapeutics, Inc. /s/ Kevin Forrest, Ph.D. Kevin Forrest, Ph.D. President and Chief Executive Officer 2016-12-05